pubmed-article:10903017 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0116569 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0018791 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0443343 | lld:lifeskim |
pubmed-article:10903017 | lifeskim:mentions | umls-concept:C0581603 | lld:lifeskim |
pubmed-article:10903017 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:10903017 | pubmed:dateCreated | 2000-11-30 | lld:pubmed |
pubmed-article:10903017 | pubmed:abstractText | Esmolol has been studied and applied to control hypertension and tachycardia during open heart surgery. Esmolol has been used on a minor scale as a single cardioplegic agent. Little information is available on esmolol as a component of blood cardioplegia. In this prospective, randomised, double-blind clinical study we investigated whether esmolol improves cardioprotection in patients scheduled for an urgent coronary operation. | lld:pubmed |
pubmed-article:10903017 | pubmed:language | eng | lld:pubmed |
pubmed-article:10903017 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10903017 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10903017 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10903017 | pubmed:issn | 0001-5172 | lld:pubmed |
pubmed-article:10903017 | pubmed:author | pubmed-author:KaukinenSS | lld:pubmed |
pubmed-article:10903017 | pubmed:author | pubmed-author:HarmoinenAA | lld:pubmed |
pubmed-article:10903017 | pubmed:author | pubmed-author:RinneTT | lld:pubmed |
pubmed-article:10903017 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10903017 | pubmed:volume | 44 | lld:pubmed |
pubmed-article:10903017 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10903017 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10903017 | pubmed:pagination | 727-32 | lld:pubmed |
pubmed-article:10903017 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:meshHeading | pubmed-meshheading:10903017... | lld:pubmed |
pubmed-article:10903017 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10903017 | pubmed:articleTitle | Esmolol cardioplegia in unstable coronary revascularisation patients. A randomised clinical trial. | lld:pubmed |
pubmed-article:10903017 | pubmed:affiliation | Department of Anaesthesia and Intensive Care, Tampere University Hospital, Finland. timo.rinne@pp.fimnet.fi | lld:pubmed |
pubmed-article:10903017 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10903017 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10903017 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10903017 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |